IRCT20200408046987N2招募中2 期
Determination the therapeutic effect of Ivermectin and Sovodak on patients infected with COVID-19: A clinical trial.
Akam Tejarat Fartak Farasoo0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 80 years（—）
- 性别
- All
入选标准
- •Patients who test positive for COVID-19 by a commercially available Test
- •Patients = 20 but < 65 years of age with a temperature (oral) of 38°C and patients 65 - 80 years of age with a temperature (oral) of 37.8°C
- •Patients with 2 or more of the following symptoms (moderate to severe in intensity) at the time of enrollment:CoughSore throatHeadacheNasal congestionFeeling feverishoBody aches and painsFatigue (tiredness)
排除标准
- •patients with Immuno deficiency
- •patients under any other antiviral therapy
研究者
相似试验
招募中
3 期
Effectiveness of Ivermectin on Outpatient Treatment of Covid-19 PatientsIRCT20210213050344N1Shiraz University of Medical Sciences375
招募中
不适用
Efficacy of Ivermectin in the treatment of COVID-19IRCT20210901052358N4Shahid Beheshti University of Medical Sciences60
尚未招募
2 期
Study to assess efficacy of Ivermectin as prophylaxis of COVID -19CTRI/2020/05/025333R D Gardi Medical College
已完成
1 期
Efficacy and safety of Ivermectin for the treatment of Plasmodium falciparum infections in asymptomatic Gabonese adultsMalariaPACTR201908520097051Centre de Recherches Medicales de Lambarene49
尚未招募
不适用
â??To study the effectiveness of Ivermectin with standard of care treatmentversus standard of care treatment for COVID 19 cases. A Pilot StudyCTRI/2020/04/024858Max Super Speciality Hospital A Unit of Devki Devi Foundation